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In this paper we describe the antibacterial effect of methylene blue,
MB, and silver nitrate reacting alone and in combination against five
bacterial strains including Serratia marcescens and Escherichia coli
bacteria. The data presented suggest that when the two compo-
nents are combined and react together against bacteria, the effects
can be up to three orders of magnitude greater than that of the sum
of the two components reacting alone against bacteria. Analysis of
the experimental data provides proof that a synergistic mechanism
is operative within a dose range when the two components react
together, and additive when reacting alone against bacteria.
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Bacterial infections cause countless deaths in humans and ani-mals. The increasing resistance and immunity of many bacteria
to antibiotics demands that an effective means for the inactivation
of bacteria becomes available that can overcome or negate the
mechanism that bacteria use to inactivate the reactive agents be-
fore they render their lethal action on those organisms. The two
antibacterial agents that we used in this study were methylene blue
(MB) and silver nitrate. Each of these alone is known to be an
effective antibacterial agent. The data presented in this study show
that they make a synergistic agent pair against the five bacteria
studied. MB is used as a bacterial inactivator for skin treatment,
dental therapy, and other areas in need of bacterial disinfection
(1–3). MB is a cation, whereas in its reduced leuco form MB has
a pKa of 5.8 and low ionization at neutral physiological pH.
This enables bacteria to reduce and inactivate MB to the leuco
form. In fact, the discoloration of MB has been an indication of the
presence of bacteria. In its cationic form, MB irradiated with 630–
680-nm light is used for cancer therapy and as an effective bacte-
ricidal and activating agent. MB is an effective antibacterial agent
owing to its ability to generate a high concentration of singlet ox-
ygen, 1O2 (
1Δg), and other reactive oxygen species, such as OH•
radicals (ROS), when irradiated with red light, which in contrast to
UV light does not harm humans or animals cells. Therefore, the
MB bacterial inactivation process is very safe and effective owing to
the high reactivity of ROS with bacterial outer-cell membrane. It is
found that the photogenerated singlet oxygen reacts against tryp-
tophan and other outer-membrane molecules, resulting in damage
to the bacterial cell and inhibiting protein production. ROS may
also create a hole in the bacterial cell wall, which allows MB rad-
icals to penetrate through the bacterial membrane and attack
DNA, forming dimers which prevent it from replicating and con-
sequently induce bacterial inactivation. The photoreaction that
generates singlet oxygen and OH• radicals proceeds as follows:
i) MB in water solution is excited to the first singlet state MB*:
MB + hν (660 nm) →MB*;
ii) MB* decays to the triplet state 3MB* with a lifetime of ∼10−9 s:
MB* → 3MB*;
iii) The triplet 3MB* transfers electrons, Rxn type I, or energy,
Rxn type II, to the ground-state molecular, triple-state oxy-
gen, 3O2 forming OH
• radicals and singlet oxygen, 1O2 (
1Δg):
3MB* + O2 →
1O2.
Both of these reactive species 1O2 (
1Δg) and OH• radicals
formed by energy transfer, type I and electron transfer, type II,
respectively, have very short reactive mean-free paths of 100 Å
and 10 Å, respectively (4, 5), which place a limit on the maximum
distance between MB and bacteria for the ROS to be effective
agents against bacteria. Positively charged photosensitizers are
expected to be more effective bacterial inactivators than neutral
molecules against Gram-negative bacteria, whose outer mem-
branes are composed of negatively charged lipopolysaccharides. In
contrast, Gram-positive bacteria may be inactivated more effec-
tively by neutral or negatively charged agents. The MB photo-
generated singlet oxygen reacts with the bacteria components
including proteins and even DNA after penetrating the cell
through the openings generated by the singlet-oxygen oxidation of
the wall membrane. Singlet oxygen is also thought to be the
dominant biocidal agent by oxidizing phospholipids, peptides, and
tryptophan, which are essential for bacteria replication. Also, 3MB*
undergoes electron transfer, type II reaction with cytoplasm to
form OH• radicals that react with pathogens, resulting in toxic
inactivation. As much as a wide range of bacteria has been found to
be susceptible to MB photodynamic therapy (PDT), no experi-
mental evidence has been published which suggests the existence of
bacteria resistant to MB PDT (6).
The second agent of this study, silver nitrate (AgNO3), has been
used as an antibacterial agent in the form of metallic silver since
ancient times. Later, in the 1800s, dilute silver nitrate was used to
prevent the transmission of Neisseria gonorrheae to newborn in-
fants and prevent infections (7, 8), and silver-coated dressings
have also been used to treat wounds and dental infections (9, 10).
The antibacterial effect of silver ions and silver nanoparticles,
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AgNPs, on Gram-positive bacteria, which are a major cause of
hospital infections, and on Gram-negative bacteria has been studied
extensively (11). A main advantage of the use of silver nitrate and
silver compounds in general, for antibacterial infections, is the fact
that Ag+ is relatively nontoxic to human and animal cells, and in
addition is very effective against fungi and viruses. It has been
reported (12) that silver nitrate kills bacteria at higher concentra-
tions than AgNPs, whereas SEM and X-ray diffraction data have
shown that at lower silver nitrate concentrations bacteria may syn-
thesize nanoparticles (13, 14). Even though the reaction of Ag+ ions
with bacteria has been studied in depth for long periods of time, the
inactivation mechanism is not entirely known and the reaction of
nanoparticles with these pathogens is even less well understood
(15). Ag+ ions are thought to attack the DNA thiol bases, forming
dimers that prevent DNA replication. AgNP and silver metal in
water solutions release silver in the form of Ag+ ions, which act as
antibacterial agents in the same manner as AgNO3. Therefore, the
reaction of these three species against bacteria is believed to be
essentially the same, although the rate of inactivation may vary
widely, most probably owing to the rate of Ag+ release. It has also
been known, for a rather long time, that Ag+ ions bind to thiol
groups containing cell membranes and enzymes, forming stable
S–Ag bonds (16), denature them, and thus prevent DNA repli-
cation by condensation (17, 18). Silver is also involved in catalytic
oxidation reactions that form R–S–S–R disulfides, which are
achieved by silver catalyzing the reaction between the oxygen
dissolved in the cell and the hydrogen of the S–H thiol group (19).
Ag+ ions, in concentration of parts per billion, have has been
known to react with maltose transporter and fructose bisphosphate
aldolase protein, causing expression decrease (20, 21). Treatment
with Ag+ has been found to degrade several proteins and associate
with the bacterial DNA after it penetrates the cell wall (22). To
that effect, we find that Ag+ enters the bacterial cell and interca-
lates between the base pair of purine and pyrimidine, thus dis-
rupting H bonding between antiparallel strands, causing the
denaturation of DNA and the subsequent inactivation of bacterial.
Our data suggest, as most investigators believe, that Ag should be
in its ionic form, Ag+, to be an effective antibacterial agent and that
silver in its metallic nonion form is rather inert (23–25). Silver ions
and the MB-induced ROS penetrate bacterial cells through their
hydrophobic membrane to access the cytoplasm. One such pathway
is the transmembrane protein that normally transports ions other
than Ag+. However, Enterococcus hirae proteins are known to
transport silver ions (26). Using these two agents, MB and AgNO3,
to react together against bacteria, we find that a synergistic effect
occurs which is thousands of times more effective in killing bacteria
than the two agents reacting alone. Experiments in vivo and in vitro
suggested that Ag+ disrupts disulfide bond formation in proteins,
which is expected to contribute to protein misfolding and aggre-
gation. Ag+ also interacts with bacteria and disrupts Fe–S clusters.
In addition, it generates superoxide formations, which cause Fe2+
leakage. These alterations in cellular morphology increase outer-
membrane permeability, which allows ROS and possibly MB to
penetrate through the membrane wall and cause bacterial in-
activation. The Ag+ and MB doses that we used have been found
to be well tolerated by mice (27), whereas the therapeutic index of
Ag+ has been calculated to vary between 8∼16, which is within the
range of the therapeutic doses approved for Food and Drug Ad-
ministration antibiotics. Ag+ was found previously to have a syn-
ergistic effect against bacteria when used in combination with
β-lactam (27), enhancing the ability of Ag+ to induce permeability
in the bacterial outer membrane.
Synergism
Many biocidal agents are not as effective against pathogens as one
would expect, or want, because the dose is often toxicity limited.
Therefore, as a means for increasing the biocidal effects of agents
while using small doses, one searches for a synergistic combination
that is more effective than the sum of its individual components
acting alone. A rather simple and accurate procedure that makes it
possible to compare the effectiveness of different agents against
bacteria is to determine the concentration or dose of each constit-
uent that produces the same quantitative effect when used alone.
Then, compare it with the effect of the two agents reacting together,
under the same conditions, against the same number of bacteria.
For example, for the case of two bacterial-killing agents, one de-
termines the concentration of agent A and then agent B, which kills
the same number of bacteria and generates a plot (isobole) of these
data. Such a plot (28), shown in Fig. 1, depicts clearly the effect of
each component A and B alone and the effect of A and B com-
ponents when used together. The shape of the resulting line pro-
vides a clear indication whether the effect is additive, straight line;
antagonistic, convex curve; or synergistic, concave curve.
Another method that we have used in this study to determine
the type of effect that is operative was to measure the number of
bacteria remaining alive after the dose of each component, f(a)
and f(b), alone and in combination, f(a + b) (28, 29). The effect is
synergistic when the sum of two components, f(a + b), reacting
together against bacteria, left a smaller number of bacteria alive
than the sum of the two components f(a) + f(b) reacting alone. To
make certain that the true mechanism of the reaction is syner-
gistic, the values of 2f(a) and 2f(b) should also be determined and
compared with the value of f(a + b), and show that 2f(a) > f(a + b)
and 2f(b) > f(a + b). The concept of synergism and the correct
means for determining whether the effect is synergistic, additive,
or antagonistic has been described in several reviews on this
subject (28, 30), and papers on its applications to various agents
(31–33), theoretical treatment, and modeling (34–36).
Another important test to determine whether the effect of two
reactants is synergistic or not may be provided by the relationship
between the doses of the two reactants A and B described by the
relationship
Dose  of   A
Ac
+
Dose  of   B
Bc
 
8<
:
  < 1,   synergistic
  = 1,   additive
  > 1,   antagonistic
, [1]
where A and B are the doses used for components A, B; and Ac
and Bc are the doses of A and B that result in the same quantitative
Fig. 1. Isoboles for synergistic, additive, and antagonistic effects. Ac and Bc
are doses of reactant A and reactant B that produce an equal effect. The
isoboles are lines that connect points of equal effect (28).
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effect, i.e., the same number of live bacteria. If the sum of these
two fractions is = 1, then the effect is additive and becomes syn-
ergistic or antagonistic if the sum of the fractions is <1, or >1,
respectively (37). A further means for deciding if the effect is
synergistic is to determine if the concentration of each antibacterial
agent, in the combination that generates the specific effect, is a
fraction of the concentration that produces the same effect when
the antibacterial agent is used alone, namely determine the frac-
tional inhibitory concentration (FIC) (29).
Experimental
Assessing the agent combination that allows for the determination
of synergy is quantitative study that requires the determination of
the individual dose(s) from which the combined and individual ef-
fect is calculated and determined. We performed a number of ex-
periments using several doses, concentration of MB, AgNO3, and
AgNP, to determine their efficacy in killing bacterial alone and in
combination with each other. Then, we used these data to determine
if the effect is synergistic or not using the fractional and geometric
isobole methods. First, we ascertained that neither AgNO3 nor silver
nanoparticles, AgNP, when irradiated with 660-nm light-emitting
diode (LED), generated ROS, which may influence their reaction
against bacteria either alone or in combination with MB. The yield
of singlet oxygen was measured by monitoring the decrease of the
399-nm absorption band of anthracene diproprionic acid salt
(ADPA), a typical probe for singlet-oxygen detection (38).
Scheme 1 shows the reaction of singlet oxygen with diproprionic
acid. It is noted that this reaction is unique to singlet oxygen and
that diproprionic acid does not react with ground-state molecular
oxygen. The amount of singlet oxygen formed is determined by the
magnitude of the slope of the reaction of ADPA, OD vs. time,
exclusively with singlet-state oxygen. The data displayed in Fig. 2
show clearly that the ADPA slope in the AgNO3 and AgNP so-
lutions is practically zero. Therefore, as stated above, no observable
singlet oxygen was produced by the photolysis of these silver
agents. In contrast, the ADPA slope is 0.029 and 0.022 in MB and
equal amounts MB + AgNO3 solutions, respectively. As expected,
this figure proves that 1O2 is generated by MB only. Therefore, the
inhibiting reaction of AgNO3 and AgNP against bacteria is not due
to photogenerated singlet oxygen or ROS, as is the case with MB.
Experiments were conducted with five different bacteria:
S. marcescens (SM), Escherichia coli, Klebsiella pneumoniae (KP),
Pseudonomas aeruginosa (PA), and Enterobacter cloacae (EC),
into which we added: (a) MB alone; (b) AgNO3 alone; (c) AgNP
alone; (d) MB + AgNO3; and (e) MB + AgNP, and determined
the biocidal effect of each of these agents alone, (a), (b), (c) and in
combination, (d), (e) against bacterial strain, while being irradi-
ated with 660-nm, 6.8-mW LED for 180 min. Subsequently, the
numbers of live bacteria were determined by the normal 24-h
incubation method and enumeration of bacteria colony-forming
units (CFUs). The number of bacteria is referred to as “logs,”
which equals log10. The experimental data are listed in Table 1. It
is evident from those data that the number of live bacteria
remaining after the combined reaction of the two agents against
bacteria is always smaller than the number of live bacteria
remaining after the sum of the two agents reacting alone against
an equal number of the same bacteria.
Fig. 3 shows the effect of the two agents acting alone and in
combination against the five bacteria studied. Fig. 3A shows the
synergistic effect of MB and AgNO3 against SM, E. coli, KP, PA,
and EC. Fig. 3B shows the synergistic effect on two different
bacterial concentrations. Fig. 3C shows that when using two dif-
ferent concentration of AgNO3, 7.75 μg/mL and 15.5 μg/mL, the
effect is also synergistic; Fig. 3D shows the effect of labeling the
MB concentration 20 to 40 μg/mL; the effect of the combined
agents against E. coli bacteria is larger than the sum of the two
components alone.
Our study shows that a synergistic effect is operative for doses
ranging from 20 to 40 μg/mL for MB and 7.75 to 15.5 μg/mL for
AgNO3. This AgNO3 dose is sublethal to mice (27). The data listed
in Table 1 show that both 2f(a) and 2f(b) doses left a larger number
of live bacteria than f(a + b); therefore, this provides proof that the
combined agent effect, f(a + b), is synergistic. The detail experi-
mental results are listed in Table 1. Below we list a set of data
recorded in one experiment.
Control: 6.3 logs (2.0 × 106), Control = SM bacteria in
plasma; MB = 20 μg/mL (6.2 × 10−5 M); AgNO3 =7.75 μg/mL
(7.2 × 10−5 M):
i) 20 μg=ml MB+ control= 5.6  logs;Live  bacteria: 4.0× 105ð5.6  logsÞ
ii) 7.75 μg=ml AgNO3 + control= 5.5  logs;Live  bacteria: 3.0× 105ð5.5  logsÞ
iii) 20 μg=ml MB+ 7.75 μg=ml AgNO3 + control= 2.7  logs;Live  bacteria: 5.0× 102ð2.7  logsÞ
For the effect to be synergistic, the number of live bacteria after
the reaction of the combined agents, f(a + b), must be less than
the sum of bacteria left alive after the two agents f(a) + f(b)
reacted alone.
Bacteria alive after agent(s) reaction with 2.0 × 106 (6.3 logs)
bacteria: f(a) = 4.0 × 105 (5.6 logs), f(b) = 3.0 × 105 (5.5 logs).
Therefore, f(a) + f(b) = 7.0 × 105 alive after reacting with 4.0 × 106
bacteria, which corresponds to 3.5 × 105 live bacteria after reacting
with 2.0 × 106 bacteria. Similarly, f(a + b) = 5.0 × 102 live after
reacting with 2.0 × 106 bacteria. Therefore, f(a + b) << f(a) + f(b)
and these data suggest that the reaction of the combined MB and
1O2
CH2CH2C
CH2CH2C
O-
O
O
O-
CH2CH2C
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O
O
O-
O
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ADPA ADPAO2
Scheme 1. Reaction of ADPA with singlet oxygen.
Fig. 2. Amount of singlet oxygen generated by eachmolecule: AgNO3 andMB
alone and both combined after illumination with 6.8-mW, 660-nm LED light.
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AgNO3 doses leaves less live bacteria than the sum of the same
doses of MB and AgNO3 reacting alone with bacteria; therefore,
the effect is synergistic.
From the perspective of bacteria killed, if the effect is synergistic,
the number of killed bacteria after the reaction of the combined
agents f(a + b) must be more than the sum of bacteria killed after
the two agents f(a) + f(b) reacted alone. Bacteria killed after
agent(s) reaction with 2.0 × 106 (6.3 logs) bacteria: f(a) = 1.6 × 106,
f(b) = 1.7 × 106. Therefore, f(a) + f(b) = 3.3 × 106 killed after
reacting with 4.0 × 106 bacteria, which corresponds to 1.6 × 106
killed after reacting with 2.0 × 106 bacteria. Similarly, f(a + b) =
1.99 × 106 killed after reacting with 2.0 × 106 bacteria.
Therefore, f(a + b) > f(a) + f(b) and the effect is further proven
to be synergistic.
In addition to SM bacteria, experiments were performed using
the bacterial strains: E. coli, KP, EC, and PA. Their reaction with
MB and AgNO3 revealed that the effect of each component
reacting alone against these bacteria is additive, whereas their
combined reaction effect is synergistic.
Fig. 4 shows that when MB and AgNO3 alone are exposed to
660-nm LED light and react alone with SM bacteria, the isobole
curve is a straight line. Therefore, the effect is additive. However,
when MB and AgNO3 are combined and react with SM bacteria
under the same conditions, the isobole curve (Fig. 5) is concave,
Table 1. Inactivation of bacteria by (a) MB alone; (b) AgNO3 alone; (a + b) MB combined with AgNO3
Live bacteria
before reaction
MB, μg/mL AgNO3, μg/mL
Bacteria remaining after 180-min irradiation of
6.8-mW, 660-nm LED
MB alone [f(a)]
AgNO3
alone [f(b)]
Same MB
and AgNO3
combined [f(a + b)]
Type Number [logs] [logs] [number] [logs] [number] [logs] [number]
SM 6.3 20 7.75 5.6 4.0 × 105 5.5 3.0 × 105 2.7 5.0 × 102
SM 6.3 20 15.5 5.6 4.0 × 105 4.6 4.0 × 104 2.2 1.6 × 102
SM 7.7 20 15.5 6.6 4.0 × 106 6.2 1.6 × 106 2.0 1.0 × 102
SM 7.7 40 15.5 5.2 1.6 × 105 6.2 1.6 × 106 1.7 5.0 × 101
E. coli 6.0 20 7.75 5.0 1.0 × 105 5.8 6.3 × 105 1.9 8.0 × 101
E. coli 7.2 20 7.75 5.9 8.0 × 105 6.6 4.0 × 106 1.9 8.0 × 101
KP 6.4 20 7.75 5.6 4.0 × 105 5.0 1.0 × 105 2.9 8.0 × 102
PA 6.6 20 7.75 6.4 2.5 × 106 6.5 3.0 × 106 2.0 1.0 × 102
EC 6.1 20 7.75 5.7 5.0 × 105 4.8 6.3 × 104 1.8 6.0 × 101
SM 6.0 20 10/AgNP 4.7 5.0 × 104 5.6 4.0 × 105 2.9 8.0 × 102
EC, E. cloacae; KP, K. pneumoniae; PA, P. aeruginosa; SM, S. marcescens.
A
C D
B
Fig. 3. Bacterial inactivation after reaction against MB alone, AgNO3 alone, and the combination of MB and AgNO3. (A) Synergistic effects of different types
of bacteria. (B) Synergistic effects of two different numbers of live bacteria. (C) Synergistic effects of two different doses of AgNO3 on the inactivation of
bacteria. (D) Synergistic effects of two different doses of MB on the inactivation of bacteria. All were irradiated with 606-nm, 6.8-mW LED light for 180 min.
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which means that the effect is synergistic. The isoboles generated
by our data show that the effect of the two agents reacting alone
against bacteria is additive; in combination the effect is synergistic.
Synergism is also the operative mechanism if the concentration
of each antibacterial component, in the combination that gener-
ates the specific effect, is a fraction of the concentration that
produces the same effect when the antibacterial agent is used
alone, namely the FIC. In our case, when MB and AgNO3 are the
two components, according to the data listed in Table 1 the sum of
these fractions is <1, which provides further confirmation that the
effect is synergistic.
We also performed similar experiments with 7.2 logs (1.6 × 107)
E. coli bacteria [American Type Culture Collection (ATCC)
25922]. In this case the dose f(a) of MB is 20 μg/mL and the dose
f(b) of AgNO3 is 7.75 μg/mL When f(a) alone is mixed with
E. coli and illuminated with the 660-nm LED for 180 min, we find
that 8.0 × 105 (5.9 logs) bacteria remain alive, whereas under
identical conditions f(b) alone left 4.0 × 106 (6.6 logs) live bacteria.
This indicates that f(a) + f(b) = 2.4 × 106 alive after reacting with
1.6 × 107 bacteria. In contrast, when the two reagents MB and
AgNO3 are combined, f(a + b), and irradiated together with
E. coli bacteria we find that 8.0 × 101 (1.9 logs) bacteria remained
alive after reacting with 1.6 × 107 bacteria. These data show
that f(a + b) << f(a) + f(b), the combination of these agents acting
together, left fewer live bacteria than the two regents reacting
alone against bacteria. Essentially, 30,000× fewer E. coli bacteria
remain alive by the two agents combined than the sum of the two
agents reacting alone with the same concentration of E. coli bac-
teria. An additional means for ascertaining the nature of the effect
is provided by substituting into Eq. 1 the corresponding values for
MB and AgNO3 where Ac and Bc are the doses of A and B that
result in the same quantitative effect
7.75
28
+
20
80
< 1.
The <1 value is an indication of synergistic effect. The same types
of isobole curves, as shown in Figs. 4 and 5, were plotted using the
data listed in Table 1, for doses of 7.75 and 15.5 μg/mL for AgNO3,
and 10 and 20 μg/mL for MB, respectively, against SM and E. coli
bacteria. We find straight isobole lines for each component react-
ing alone and concave isoboles for the two agents’ combined effect.
These curves show that the effect of the combined doses is syner-
gistic and the effect of individual components alone is additive. The
synergistic effect under different illumination times of the 660-nm
LED is shown in Fig. S1.
Although the mechanism for the synergistic effect observed for
the combined MB/AgNO3 reaction of against bacteria is not
completely known at the present time, experimental studies in
progress suggest that Ag+ ions, interacting with the outer mem-
brane of Gram-negative bacteria, generate channels with openings
large enough for the MB reagent to penetrate the bacterial wall
and enter the interior of the cell. This enables the MB photo-
generated singlet oxygen, OH• radicals, and MB radicals to be in
contact and react directly with bacterial components including
tryptophan and oxidize it, thus inhibiting protein formation and
even forming DNA dimers which prevent bacterial replication.
There is a possibility of peroxide formation which will also react
with the bacterial membrane. This process enhances, several-fold,
the effectiveness of MB against Gram-negative bacteria and partly
explain the observed AgNO3/MB synergistic effect. Our pre-
liminary experimental data and previously published results (27)
indicate that a major factor for the observed synergistic effect is the
ability of silver ions to interact with the outer membrane of Gram-
negative bacteria and increase its permeability to MB, enabling the
MB photogenerated ROS to oxidize several bacterial components
including DNA and consequently kill bacteria with high efficacy.
We are studying these and other reactions to determine the
mechanism(s) responsible for the observed synergetic effect of
silver ions and nanoparticles in conjunction with MB irradiated
with the 660-nm red light.
Even though the biocide reactions of silver nitrate and AgNO3
are well documented, their use as antibacterial agents in open
wounds is not widely recommended because there is evidence that
high doses of silver ions are harmful to human tissue (39, 40). To
understand the toxic effect, if any, that the MB/AgNO3 synergistic
effect has on live tissue, we performed experiments using fetal
foreskin fibroblasts.
Fetal foreskin fibroblasts were grown to confluence in 48-well
microtiter plates. In parallel, rows on the plate were placed in:
(i) plain culture medium, (ii) a solution of AgNO3 diluted one-to-
one in plasma to reach a final concentration of 33 μg/mL, (iii) a
solution of AgNO3 diluted one-to-one in plasma to reach a final
concentration of 15.5 μg/mL, (iv) plasma alone, (v) MB diluted
one-to-one in plasma to reach a final concentration of 20 μg/mL,
(vi) a solution of AgNO3 at a final concentration of 15.5 μg/mL
with MB at a final concentration of 20 μg/mL diluted one-to-one in
plasma. One half of the plate was covered in aluminum foil and the
plate was placed under a red light and excited at 660 nm for 3 h at a
temperature of 34 °C. The light flux was 6.8 mW. At the comple-
tion of the period of irradiation, each well was inspected by light
microscopy. The cells on all rows were intact save for those cells
exposed to AgNO3 at 33 μg/mL, which were detached and frag-
mented. A commercial preparation of trypan blue was then added
to two columns of the plate at the appropriate concentration and
the cells were again inspected after 15 min and every day thereafter
BA
Fig. 4. (A) MB dose vs. SM bacterial killing; (B) AgNO3 dose vs. SM bac-
terial killing.
Fig. 5. Isobole plot. Doses of MB and AgNO3 that have the same effect on
SM bacteria.
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for 72 h and again at 7 d. All of the cells that remained attached to
the bottom of the wells of the plate, including those exposed to the
lower concentration of MB and AgNO3 combined, excluded trypan
blue for the entire 7-d observation period and continued to be
intact. Thus, the fetal foreskin fibroblasts remained viable after
exposure to the MB/AgNO3 preparations used to kill the bacteria
tested here.
These results show that using the doses of our synergistic
effect experiments, 20 μg/mL MB and 7.75 μg/mL AgNO3, the
MB/AgNO3 combination may be used for bacteria inactivation
in open wounds and other therapeutic applications.
Conclusion
The data and analysis presented show that when MB and AgNO3
are combined and react together against five different bacteria,
the effect is synergistic, within a dose(s) limit. The number of
bacteria that remain alive after the reaction of the combined two
agents is about three orders of magnitudes smaller than the sum of
the two agents reacting alone against the same number of bacteria.
These data allow one to determine the dose combination that is
optimal for pathogen inactivation and effective elimination of
bacterial infections. Possible application of this antibacterial syn-
ergistic system is for the in situ treatment of burn wounds and
many other infections, including water disinfection. Fetal foreskin
fibroblasts grown to confluence, placed in plasma, MB, AgNO3,
andMB/AgNO3 combination and irradiated with 660-nm, 6.8-mW
light for 3 h remain viable, suggesting that our MB/AgNO3 com-
bination maybe used effectively in wound therapy.
Materials and Methods
The bacteria presented in this study were purchased from the ATCC Manassas;
MB and AgNO3 were purchased from Sigma-Aldrich and used without further
purification; ADPA was purchased from Chemodex and kept refrigerated until
use. The absorption spectra of MB and ADPA were measured using a Shimatsu
1600 UV spectrophotometer, in 1-mm optical path-length quartz cells. The
concentration of single oxygen, 1O2 (
1Δg), generated by MB (Fig. 2) was de-
termined by the decrease in the OD of ADPA at 399 nm. The concentration
of MB and AgNO3 solutions, (i) AgNO3 + ADPA, (ii) MB + ADPA, (iii) AgNO3 +
MB + ADPA, were kept the same for all measurements. The 660-nm, mono-
chromatic LED light was focused onto the cell with a 25-cm lens and the power,
6.8 mW, was measured by a Molectron PM3Q detector. After each irradiation,
the absorption spectrum was measured and the OD at 399 nm was plotted vs.
irradiation time (Fig. 2). Bacteria were added to PBS or plasma solvents. The
number of bacteria was determined by the normal 24-h incubation method, in
agar, at 30∼37 °C and then counting the CFUs. Fetal foreskin fibroblasts were
grown to confluence in 48-well microtiter plates and allowed to react with MB
and AgNO3 combined and inspected by light microscopy.
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